SEER Inquiry System - Search

Reports can contain records from numerous searches. All records marked "Add to Report" will be added to an existing report until the report set is cleared. Use this link to: Clear questions marked for reportUndo clear all

Search

Search text of SINQ issues for specific words:

Word

Word

Word

From Years:

From 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

To 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

Quick Search

Detailed Search [show]

Question ID  (ex. 20080001)
  

Category

Search for SINQ issues by assigned categories
And
Or

Category #1
2004 SEER Manual Errata Ambiguous terminology BRM Behavior Birthplace Bladder Brain and CNS Breast CLL/SLL CS Eval CS Extension CS Lymph Nodes CS Mets at DX CS Reg LN Pos/Exam CS Site Specific Factor CS Tumor Size Cancer-directed treatment Cell indicator Cervix Uteri Chemotherapy Collaborative Staging Colon Computer generated fields Corpus uteri DCO Date 1st surgical procedure Date Multiple Tumors Date of Conclusive Termin Date of diagnosis Date therapy initiated Diagnostic confirmation EOD 2018 Esophagus Extension First course treatment Flag Glioblastoma Grade Head & Neck Hematopoietic, NOS Heme & Lymphoid Neoplasms Histology Immunotherapy In Situ Kidney, renal pelvis Laterality Leukemia Lung Lymph nodes Lymph nodes-EOD Lymphoma MP/H Rules Marital Status Melanoma Mets at diagnosis fields Multiple primaries Multiplicity Counter Neoadjuvant treatment Other therapy Ovary Pancreas Polyp Primary site Priorities Prostate Race, ethnicity Radiation Therapy Reason no treatment Reconstruction Recurrence Reportability Reporting Source Residence at dx Retinoblastoma SEER Summary Stage 2000 Sarcoma Scope Regional LN Surgery Seq no-central Sex Size of tumor Skin Solid Tumor Rules (2018) Stomach Summary Stage - 1977 Summary Stage 2018 Surgery codes, NOS Surgery of Primary Site Systemic / Surgery Sequen Terminology, NOS Terms of involvement Thyroid Treatment, NOS Tumor markers Type of Multiple Tumors Unknown & ill-defined sit Wilm's Tumor Category #2
2004 SEER Manual Errata Ambiguous terminology BRM Behavior Birthplace Bladder Brain and CNS Breast CLL/SLL CS Eval CS Extension CS Lymph Nodes CS Mets at DX CS Reg LN Pos/Exam CS Site Specific Factor CS Tumor Size Cancer-directed treatment Cell indicator Cervix Uteri Chemotherapy Collaborative Staging Colon Computer generated fields Corpus uteri DCO Date 1st surgical procedure Date Multiple Tumors Date of Conclusive Termin Date of diagnosis Date therapy initiated Diagnostic confirmation EOD 2018 Esophagus Extension First course treatment Flag Glioblastoma Grade Head & Neck Hematopoietic, NOS Heme & Lymphoid Neoplasms Histology Immunotherapy In Situ Kidney, renal pelvis Laterality Leukemia Lung Lymph nodes Lymph nodes-EOD Lymphoma MP/H Rules Marital Status Melanoma Mets at diagnosis fields Multiple primaries Multiplicity Counter Neoadjuvant treatment Other therapy Ovary Pancreas Polyp Primary site Priorities Prostate Race, ethnicity Radiation Therapy Reason no treatment Reconstruction Recurrence Reportability Reporting Source Residence at dx Retinoblastoma SEER Summary Stage 2000 Sarcoma Scope Regional LN Surgery Seq no-central Sex Size of tumor Skin Solid Tumor Rules (2018) Stomach Summary Stage - 1977 Summary Stage 2018 Surgery codes, NOS Surgery of Primary Site Systemic / Surgery Sequen Terminology, NOS Terms of involvement Thyroid Treatment, NOS Tumor markers Type of Multiple Tumors Unknown & ill-defined sit Wilm's Tumor Category #3
2004 SEER Manual Errata Ambiguous terminology BRM Behavior Birthplace Bladder Brain and CNS Breast CLL/SLL CS Eval CS Extension CS Lymph Nodes CS Mets at DX CS Reg LN Pos/Exam CS Site Specific Factor CS Tumor Size Cancer-directed treatment Cell indicator Cervix Uteri Chemotherapy Collaborative Staging Colon Computer generated fields Corpus uteri DCO Date 1st surgical procedure Date Multiple Tumors Date of Conclusive Termin Date of diagnosis Date therapy initiated Diagnostic confirmation EOD 2018 Esophagus Extension First course treatment Flag Glioblastoma Grade Head & Neck Hematopoietic, NOS Heme & Lymphoid Neoplasms Histology Immunotherapy In Situ Kidney, renal pelvis Laterality Leukemia Lung Lymph nodes Lymph nodes-EOD Lymphoma MP/H Rules Marital Status Melanoma Mets at diagnosis fields Multiple primaries Multiplicity Counter Neoadjuvant treatment Other therapy Ovary Pancreas Polyp Primary site Priorities Prostate Race, ethnicity Radiation Therapy Reason no treatment Reconstruction Recurrence Reportability Reporting Source Residence at dx Retinoblastoma SEER Summary Stage 2000 Sarcoma Scope Regional LN Surgery Seq no-central Sex Size of tumor Skin Solid Tumor Rules (2018) Stomach Summary Stage - 1977 Summary Stage 2018 Surgery codes, NOS Surgery of Primary Site Systemic / Surgery Sequen Terminology, NOS Terms of involvement Thyroid Treatment, NOS Tumor markers Type of Multiple Tumors Unknown & ill-defined sit Wilm's Tumor
Last Updated Since
(mm/dd/yyyy)

Finalized Since
(mm/dd/yyyy)

Free Text

(each text box will be treated as a phrase)
And Or

Phrase 1
Phrase 2
Phrase 3
Phrase 4

Year of Question

Less Than Equal To Greater Than
  

Note: blanks are ignored

Display Options [hide]

Fields To Display

Status Category References Question Discussion Answer History Last Updated Date Finalized

Output Format

List Questions Individually List Questions in Table